logo
16:01 Jan 21

Gennex Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
13.03
-0.03 (-0.23%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Gennex Laboratories Ltd. Financials

Gennex Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
13.03
-0.03 (-0.23%)
16:01 Jan 21
Quality
image/svg+xml

52/100
Medium Financial Strength

Valuation
image/svg+xml

43/100
Mid Valuation

Technical

45/100
Technically Neutral

Strength

10

Weakness

4

Opportunity

0

Threats

0

9.70 %

ROE %

7.07 %

ROA %

0.00

EPS

8.21

BVPS

13.14 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
61.21 65.6 86.71 137.9 151.76
Operating Expenses +
55.83 60.91 69.68 121.19 132.18
Raw Material
40.01 46.91 57.88 100.59 116.06
Increase Decrease in Cost
-1.91 -7 -9.03 -3.51 -8.47
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
6.97 7.87 7.79 8.35 8.67
Miscellaneous Expenses
10.76 13.13 13.04 15.76 15.92
Operating Profit
5.38 4.69 17.03 16.71 19.58
Other Income
1.38 3.95 4.91 10.43 8.17
Depreciation
0.79 0.92 2.37 1.99 2
Interest
0.88 1.35 3.08 3.61 4.05
Profit before tax and exceptio..
5.09 6.37 16.49 21.55 21.7
Exceptional Items
0 0 0 -0.15 0
PBT
5.09 6.37 16.49 21.4 21.7
Provision for Taxation
1.17 1.45 3.32 3.27 3.03
Net Profit
3.92 4.92 13.18 18.12 18.67
NET Profit after MI
3.92 4.92 13.18 18.12 22.35
EPS
0.33 0.42 0.66 0.78 0.8
Operating Profit Margin (%)
8.79 7.15 19.64 12.12 12.9
Net Profit Margin (%)
6.4 7.5 15.2 13.14 14.73

Gennex Laboratories Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 23.60 23.60 19.80 18.40 18.40 18.40
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 76.40 76.40 80.20 81.60 81.60 81.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: